Cargando…

CDNF Protein Therapy in Parkinson’s Disease

Neurotrophic factors (NTF) are a subgroup of growth factors that promote survival and differentiation of neurons. Due to their neuroprotective and neurorestorative properties, their therapeutic potential has been tested in various neurodegenerative diseases. Bioavailability of NTFs in the target tis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huttunen, Henri J., Saarma, Mart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628563/ https://www.ncbi.nlm.nih.gov/pubmed/30947516 http://dx.doi.org/10.1177/0963689719840290

Ejemplares similares

Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra
por: Mätlik, Kert, et al.
Publicado: (2017)

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
por: Bäck, Susanne, et al.
Publicado: (2013)

CDNF and MANF regulate ER stress in a tissue-specific manner
por: Pakarinen, Emmi, et al.
Publicado: (2022)

Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy
por: Galli, Emilia, et al.
Publicado: (2019)

Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease
por: Garea-Rodríguez, Enrique, et al.
Publicado: (2016)

Characterization of the Structural and Functional Determinants of MANF/CDNF in Drosophila In Vivo Model
por: Lindström, Riitta, et al.
Publicado: (2013)

Protection of dopamine neurons by CDNF and neurturin variant N4 against MPP(+) in dissociated cultures from rat mesencephalon
por: Jaumotte, Juliann D., et al.
Publicado: (2021)

CDNF Interacts with ER Chaperones and Requires UPR Sensors to Promote Neuronal Survival
por: Eesmaa, Ave, et al.
Publicado: (2022)

Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage
por: Tseng, Kuan-Yin, et al.
Publicado: (2023)

CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease
por: Pakarinen, Emmi, et al.
Publicado: (2023)

Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action
por: Voutilainen, Merja H., et al.
Publicado: (2017)

Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra
por: Nadella, Rasajna, et al.
Publicado: (2014)

CDNF rescues motor neurons in models of amyotrophic lateral sclerosis by targeting endoplasmic reticulum stress
por: De Lorenzo, Francesca, et al.
Publicado: (2023)

Endoplasmic Reticulum Stress Regulators: New Drug Targets for Parkinson’s Disease
por: Kovaleva, Vera, et al.
Publicado: (2021)

Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies
por: Chmielarz, Piotr, et al.
Publicado: (2020)

A Comparative Analysis of the Molecular Features of MANF and CDNF
por: Norisada, Junpei, et al.
Publicado: (2016)

Trophic Factors in Inflammation and Regeneration: The Role of MANF and CDNF
por: Sousa-Victor, Pedro, et al.
Publicado: (2018)

Neurotrophic Factors in Parkinson’s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain
por: Bondarenko, Olesja, et al.
Publicado: (2021)

Human-Specific Regulation of Neurotrophic Factors MANF and CDNF by microRNAs
por: Konovalova, Julia, et al.
Publicado: (2021)

Genetically Targeted Clinical Trials in Parkinson’s Disease: Learning from the Successes Made in Oncology
por: Sjögren, Magnus, et al.
Publicado: (2021)

The Effect of RADA16-I and CDNF on Neurogenesis and Neuroprotection in Brain Ischemia-Reperfusion Injury
por: Liu, Xingyu, et al.
Publicado: (2022)

c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease
por: Lindholm, Dan, et al.
Publicado: (2016)

Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson’s Disease
por: Galli, Emilia, et al.
Publicado: (2019)

Recombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicity
por: Wang, Lizheng, et al.
Publicado: (2017)

Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism
por: Lindholm, Päivi, et al.
Publicado: (2021)

Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration
por: Sidorova, Yulia A., et al.
Publicado: (2020)

Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington’s disease
por: Stepanova, P., et al.
Publicado: (2020)

GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop
por: Barker, Roger A., et al.
Publicado: (2020)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease
por: Stepanova, P., et al.
Publicado: (2023)

Association between cerebral dopamine neurotrophic factor (CDNF) 2 polymorphisms and schizophrenia susceptibility and symptoms in the Han Chinese population
por: Yang, Yongfeng, et al.
Publicado: (2018)

Modulating Microglia/Macrophage Activation by CDNF Promotes Transplantation of Fetal Ventral Mesencephalic Graft Survival and Function in a Hemiparkinsonian Rat Model
por: Tseng, Kuan-Yin, et al.
Publicado: (2022)

Mechanisms of secretion and spreading of pathological tau protein
por: Brunello, Cecilia A., et al.
Publicado: (2019)

Cerebral Dopamine Neurotrophic Factor (CDNF) Has Neuroprotective Effects against Cerebral Ischemia That May Occur through the Endoplasmic Reticulum Stress Pathway
por: Zhang, Geng-Lin, et al.
Publicado: (2018)

Netrin‐1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson’s disease features
por: Jasmin, Mélissa, et al.
Publicado: (2020)

The role of SorLA in neurotrophic activity and complex behavior
por: Glerup, Simon, et al.
Publicado: (2013)

Exploring the Conserved Role of MANF in the Unfolded Protein Response in Drosophila melanogaster
por: Lindström, Riitta, et al.
Publicado: (2016)

Therapy of Parkinson's Disease
por: Holzer, Jacob C.
Publicado: (1990)

Secondary Pathology of the Thalamus after Focal Cortical Stroke in Rats is not Associated with Thermal or Mechanical Hypersensitivity and is Not Alleviated by Intra-Thalamic Post-Stroke Delivery of Recombinant CDNF or MANF
por: Anttila, Jenni E., et al.
Publicado: (2019)

Protein Kinases and Parkinson’s Disease
por: Mehdi, Syed Jafar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2959q3lm3joemgo6gvhv9ouglf